The Association Between HLA-DPB1Glu69 and Chronic Beryllium Disease and Beryllium Sensitization
Public Domain
-
2004/08/01
-
Details
-
Personal Author:
-
Description:Several case-control studies have found an association between chronic beryllium disease (CBD) and HLA-DPB1 gene variants. However, the relationship between HLA-DPB1 and beryllium sensitization, and whether the presence of one or two HLA-DPB1(Glu69) alleles is differentially associated with CBD and beryllium sensitization have not been completely resolved. Restriction fragment length polymorphism (RFLP) analysis was used to address these questions in a large population-based cohort consisting of 884 beryllium workers (90 with CBD, 64 beryllium sensitized). HLA-DPB1(Glu69) was associated with both CBD (OR = 9.4; 95% CI = 5.4, 16.6) and sensitization (OR = 3.3, 95% CI = 1.9, 5.9). Further, workers with CBD and sensitization were more likely to be homozygous HLA-DPB1(Glu69) compared to workers without disease or sensitization (P < 0.001). Follow-up of this cohort, scrutiny of HLA-DPB1 haplotypes, and evaluation of gene-environment and gene-gene interactions will be important for fully understanding the immunogenetic nature of this occupational disease. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0271-3586
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:95-103
-
Volume:46
-
Issue:2
-
NIOSHTIC Number:nn:20025456
-
Citation:Am J Ind Med 2004 Aug; 46(2):95-103
-
Contact Point Address:Ainsley Weston, NIOSH/HELD/TMBB, 1095 Willowdale Road, Morgantown, WV 26505
-
Email:agw8@cdc.gov
-
CAS Registry Number:
-
Federal Fiscal Year:2004
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:American Journal of Industrial Medicine
-
Collection(s):
-
Main Document Checksum:urn:sha-512:4ce249da1b25f5159b19cbf96aa8cba7b4acd3775c6cc9c9acbf6a7cb5cd7232d2698e07e50b4959826e378b507097b9fdcfa41d1e8e7a231f8e309ad951bbcd
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like